Lisata Therapeutics, Inc. (LSTA) Insider Trading Activity

NASDAQ$1.06-0.03 (-2.75%)
Market Cap
$9.82M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
634 of 849
Rank in Industry
364 of 491

LSTA Insider Trading Activity

LSTA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a …

Insider Activity of Lisata Therapeutics, Inc.

Over the last 12 months, insiders at Lisata Therapeutics, Inc. have bought $0 and sold $0 worth of Lisata Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Lisata Therapeutics, Inc. have bought $30,190 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 33,785 shares for transaction amount of $30,190 was made by MYERS STEVEN S (director) on 2021‑12‑08.

List of Insider Buy and Sell Transactions, Lisata Therapeutics, Inc.

2021-12-08PurchaseMYERS STEVEN Sdirector
33,785
0.1303%
$0.89
$30,190
-42.39%
Total: 1

Insider Historical Profitability

<0.0001%
MYERS STEVEN Sdirector
146839
1.6296%
$160,054.5110
<0.0001%

Historical Insider Profitability vs. Competitors

$18,815,063
62
-6.45%
$13.7M
$95,567,744
39
-17.01%
$10.94M
$30,257,839
29
-15.72%
$12M
$76,600
22
-38.58%
$10.49M
$555,628
21
43.52%
$12.04M

LSTA Institutional Investors: Active Positions

Increased Positions13+56.52%30,832+4.1%
Decreased Positions8-34.78%54,934-7.31%
New Positions6New6,080New
Sold Out Positions2Sold Out11,115Sold Out
Total Postitions28+21.74%727,244-3.21%

LSTA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$530.003.01%270,514+16,332+6.42%2025-09-30
Renaissance Technologies Llc$229.001.3%116,622+13,800+13.42%2025-09-30
Bml Capital Management, Llc$215.001.22%109,841-99,973-47.65%2025-09-30
Geode Capital Management, Llc$124.000.7%63,260+2,178+3.57%2025-09-30
Blackrock, Inc.$108.000.61%54,890+33+0.06%2025-09-30
Ground Swell Capital, Llc$47.000.26%23,774+23,774New2025-09-30
Dimensional Fund Advisors Lp$41.000.23%20,947-4,846-18.79%2025-09-30
State Street Corp$28.000.16%14,34800%2025-09-30
Cerity Partners Llc$24.000.14%12,18300%2025-09-30
Cook Wealth, Llc$24.000.14%12,17500%2025-03-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.